These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39045999)

  • 1. ASSOCIATION BETWEEN ANXIETY AND DEPRESSION IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD).
    Botacin EC; Duarte SMB; Stefano JT; Barbosa MED; Pessoa MG; Oliveira CP
    Arq Gastroenterol; 2024; 61():e23128. PubMed ID: 39045999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between depressive symptoms and cognitive impairment in patients with metabolic syndrome.
    Kopchak O; Pulyk O
    Wiad Lek; 2017; 70(4):737-741. PubMed ID: 29064796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study.
    Butnoriene J; Steibliene V; Saudargiene A; Bunevicius A
    BMC Psychiatry; 2018 Jan; 18(1):5. PubMed ID: 29310620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of depression and anxiety among subjects with metabolic syndrome and known type 2 diabetes mellitus - a population-based study.
    Shinkov A; Borissova AM; Kovatcheva R; Vlahov J; Dakovska L; Atanassova I; Petkova P
    Postgrad Med; 2018 Mar; 130(2):251-257. PubMed ID: 29185828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety.
    Zhong Y; Hu M; Wang Q; Yang Z; Zhu N; Wang F; Zhang X; Zhang C; Min J; Wang H; Chen F; Zhao X; Zhang X
    Sci Rep; 2021 Feb; 11(1):3324. PubMed ID: 33558554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of anal incontinence in the elderly population: an epidemiological study of the elderly population served at the geriatric ambulatory service of the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo].
    Lopes MC; Teixeira MG; Jacob Filho W; Carvalho Filho ET; Habr-Gama A; Pinotti HW
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(1):1-12. PubMed ID: 9334464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Syndrome, Anxiety and Depression in a Sample of Italian Primary Care Patients.
    Mattei G; Padula MS; Rioli G; Arginelli L; Bursi R; Bursi S; Epifani AM; Pingani L; Rigatelli M; Rosato FM; Sacchetti A; Galeazzi GM; Ferrari S
    J Nerv Ment Dis; 2018 May; 206(5):316-324. PubMed ID: 29658910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between anxiety, depression, and the metabolic syndrome.
    Skilton MR; Moulin P; Terra JL; Bonnet F
    Biol Psychiatry; 2007 Dec; 62(11):1251-7. PubMed ID: 17553465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The scores of Hamilton depression, anxiety, and panic agoraphobia rating scales in patients with acute coronary syndrome.
    Vural M; Acer M; Akbaş B
    Anadolu Kardiyol Derg; 2008 Feb; 8(1):43-7. PubMed ID: 18258533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioelectrical impedance parameters add incremental value to waist-to-hip ratio for prediction of metabolic dysfunction associated steatotic liver disease in youth with overweight and obesity.
    Song K; Seol EG; Yang H; Jeon S; Shin HJ; Chae HW; Kim EK; Kwon YJ; Lee JW
    Front Endocrinol (Lausanne); 2024; 15():1385002. PubMed ID: 38883602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the metabolic syndrome on health-related quality of life: a cross-sectional study in Greece.
    Tziallas D; Kastanioti C; Kostapanos MS; Skapinakis P; Elisaf MS; Mavreas V
    Eur J Cardiovasc Nurs; 2012 Sep; 11(3):297-303. PubMed ID: 21398183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity.
    Brodosi L; Stecchi M; Musio A; Bazzocchi M; Risi E; Marchignoli F; Marchesini G; Petroni ML
    Acta Diabetol; 2024 Aug; 61(8):1041-1051. PubMed ID: 38684539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression in systemic lupus erythematosus: gender differences in the performance of the Beck Depression Inventory (BDI), Center for Epidemiologic Studies Depression Scale (CES-D), and Hospital Anxiety and Depression Scale (HADS).
    Macêdo EA; Appenzeller S; Costallat LTL
    Lupus; 2018 Feb; 27(2):179-189. PubMed ID: 28587586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.
    Nègre-Pagès L; Grandjean H; Lapeyre-Mestre M; Montastruc JL; Fourrier A; Lépine JP; Rascol O;
    Mov Disord; 2010 Jan; 25(2):157-66. PubMed ID: 19950403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active disease is independently associated with more severe anxiety rather than depressive symptoms in patients with systemic lupus erythematosus.
    Tay SH; Cheung PP; Mak A
    Lupus; 2015 Nov; 24(13):1392-9. PubMed ID: 26085594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Anxiety and Depressive Symptoms in the Early Post-stroke Period.
    Todorov V; Dimitrova M; Todorova V; Mihaylova E
    Folia Med (Plovdiv); 2020 Dec; 62(4):695-702. PubMed ID: 33415913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the presence and severity of menopausal symptoms among postmenopausal women screened for the metabolic syndrome.
    Chedraui P; Pérez-López FR; Hidalgo L; Villacreses D; Domínguez A; Escobar GS; Genazzani AR; Simoncini T;
    Gynecol Endocrinol; 2014; 30(12):918-24. PubMed ID: 25347000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease/Non-alcoholic Fatty Liver Disease With Type 2 Diabetes Mellitus: A Case-Control Study in a Tertiary Care Hospital in Pakistan.
    Zahoor F; Saeed NU; Javed S; Sadiq HZ; Mand Khan F; Haider M; Shafqat MN; Maqbool A; Chaudhry A
    Cureus; 2023 Oct; 15(10):e47240. PubMed ID: 38021965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of metabolic syndrome severity on racial and ethnic disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Elsaid MI; Bridges JFP; Mumtaz K; Li N; Sobotka L; Rustgi VK; Paskett ED
    PLoS One; 2024; 19(3):e0299836. PubMed ID: 38489287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and factors associated with depression and anxiety in patients with psoriasis.
    Pollo CF; Miot HA; Matos TDS; de Souza JM; Jorge MFS; Miot LDB; Meneguin S
    J Clin Nurs; 2021 Feb; 30(3-4):572-580. PubMed ID: 33258200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.